Matthew Crapko, MD
Colon & Rectal Surgery · Reno, NVNPI 1922273903
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,088 of the $1,543 with a category attached, or 70.5%. 7 manufacturers reported payments, led by Intuitive Surgical at 59.5% of the total. Reporting peaked in 2023 at $900 and has fallen 65.1% since, to $315 in 2025.
Across 17 payments — averaging $90.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$918
- TELA Bio, Inc.$230
- Johnson & Johnson$189
- Davol Inc.$116
- BD$41
- Biom'up France SAS$33
- plus $17 from 1 others
What the payments were for
- Travel & lodging$43828%
- Food & beverage$1,08871%
- Gifts$161%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 8 | $918 |
| TELA Bio, Inc. | 3 | $230 |
| Johnson & Johnson | 2 | $189 |
| Davol Inc. | 1 | $116 |
| BD | 1 | $41 |
| Biom'up France SAS | 1 | $33 |
| Solventum Corporation | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
Too few colon & rectal surgery providers in Nevadato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 35 | $266 |
| Neomycin Sulfate | 30 | $168 |
| Metronidazole | 30 | $44 |
Paid to pharmacies, not to this prescriber.
Other colon & rectal surgery in Reno
- Kent SasseReno$44K
- Anathea PowellReno$6K
- Harold KennedyReno$51
- Garrett FriedmanLas Vegas$1.2M
- Roger HsiungLas Vegas$44K
- Leslie BrowderNorth Las Vegas$10K
- Ren Yu ZhangLas Vegas$8K
- Ketan ThankiLas Vegas$7K
- Calvin LyonsLas Vegas$6K
- Melissa MilesLas Vegas$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.